Articles
27. 10. 2015 Cancer in the older population of the Czech Republic
Population ageing has become a challenge to cancer care in developed countries. Particularities of the older population must be taken into account when considering cancer treatment. However, there is a lack of consensus on guidelines for this population due to the underrepresentation of older patients in clinical trials.
15. 1. 2014 Personalised invitations of Czech citizens to cancer screening programmes
In January 2014, a project of personalised invitations for cancer screening programmes was launched in the Czech Republic. In particular, citizens are invited to participate in colorectal cancer screening (men and women), as well as breast cancer screening and cervical cancer screening (women). Personalised invitations are aimed at citizens who have not participated in cancer screening programmes in the long term, and therefore are at a higher risk of developing cancer. The project is expected to increase participation rates in Czech cancer screening programmes.
» Archive
Screening mammography is linked to a reduction in breast cancer mortality, a new study shows
Yet another study has confirmed that the introduction of screening mammography is linked to a subsequent decline in breast cancer mortality. New findings have just been published in the Journal of Medical Screening [1].
A team of researchers from the School of Public Health and Community Medicine at the the University of New South Wales in Sydney (Australia) and BreastScreen Aotearoa, Wellington (New Zealand) investigated trends in breast cancer mortality in New Zealand women in order to either corroborate or negate a causal association with service screening mammography.
Cumulated mortality rates from breast cancer deaths individually linked to incident cases diagnosed before and after screening commencement were compared, in women aged 50-64 (from 2001) and aged 45-49 and 65-69 (from 2006). Trends and differences in aggregate invasive breast cancer mortality (1975-2013) were assessed in relation to introduction of mammography screening targeting women aged 50-64 and 45-69.
It was found that incidence-based cumulated breast cancer mortality before and after the introduction of screening was reduced by 15% for women aged 45-69 and by 17% for those aged 50-64. Aggregate mortality declined by 34% (2005-13 compared with 1992-98) in the age group 50-64, by 28% among women aged 45-49 and by 25% among women aged 65-74.
The authors concluded that breast cancer mortality declines occurring since the advent of screening mammography in New Zealand are consistent with other incidence-based and aggregate studies of screening mammography in populations, individual-based cohort studies and randomised controlled trials.
Reference
- Taylor R, Gregory M, Sexton K, Wharton J, Sharma N, Amoyal G, Morrell S. Breast cancer mortality and screening mammography in New Zealand: Incidence-based and aggregate analyses. Journal of Medical Screening 2018. doi: 10.1177/0969141318776039
Keywords: breast cancer mortality, screening mammography, New Zealand
12. 6. 2018 Journal of Medical Screening